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Haemorrheologic and fibrinolytic activities in pregnancy have been scarcely examined in Nigeria 
especially on the influences of gestational age and parity. In order to assess these influences, 100 
pregnant and 100 non pregnant subjects (controls) of age range 18 – 40 years were studied. Packed cell 
volumes (PCV), relative whole blood viscosity (RWBV), relative plasma viscosity (RPV), plasma 
fibrinogen concentration (PFC), euglobulin lysis time (ELT), total proteins and albumin were estimated. 
The differences in the values of PCV, RWBV, RPV, PFC, total proteins, albumin and globulin with 
gestational age were not statically significant (P>0.05) while the values of ELT decreased with increase 
in gestational age (P < 0.01). The differences in the values of PCV, RWBV, RPV, PFC, ELT, total proteins, 
albumin and globulin with parity were not statistically significant (P > 0.05). In conclusion, this study 
has shown that gestational age and parity had little or no effect on the haemorrheologic and fibrinolytic 
activities during pregnancy.  
 





The magnitude of the increase in the blood volume during 
pregnancy varies due to the number of pregnancies, 
infants and fetuses (Koos and Moore, 2003). Plasma 
volume increases earlier in pregnancy and faster than red 
blood cell volume leading to the fall of haematocrit until 
the end of second trimester when the increase in red 
blood cells is synchronized with the plasma volume 
increase (Koos and Moore, 2003; Stuart and Christoph, 
2000). 
Physiological changes characterized by haemodilution, 
increased levels of plasma proteins and reduced 
fibrinolytic activity have been observed in pregnancy 
(Tommaso et al., 1991; Bennett et al., 1993; Adediran et 
al., 1999) . 
Plasma fibrinogen concentrations have been observed 
to increase during the third month of pregnancy and 
progressively rise until late pregnancy (Koos and Moore, 
2003; Akinsete and Uyanwah (1989) while euglobulin 
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advanced in age (Akinsete and Uyanwah, 1989). 
Increase in blood viscosity and plasma viscosity in the 
third trimester of pregnancy and subsequent fall with 
advancing gestation has been reported (Kametas et al., 
2001) while some women in the final three months of 
pregnancy have been observed to have increase in 
plasma viscosity (Harkness and Whittington, 1971).  
Haemorrheologic and fibrinolytic activities have been 
scarcely examined in Nigeria especially on the influence 
of gestational age and parity which therefore necessi-
tated this study. 
 
 
MATERIALS AND METHODS 
 
The study was carried out from January to June, 2007 after the 
Ethical Committee of the University of Calabar Teaching Hospital, 
Calabar had approved the study. Informed consent of each of the 
one hundred (100) apparently healthy subjects attending the 
antenatal clinic in the hospital and 100 non pregnant subjects 
(controls) of similar age of 18 - 40 years was duly obtained. Apart 
from the subjects living within Calabar metropolis, the entire 
apparently healthy subjects studied were of systolic blood pressure 
of 90 – 130 mmHg and diastolic blood pressure of 60 – 90 mmHg 
with absence of protein and glucose in their urine.  
Eight ml of venous blood was asceptically collected into a dispos- 




Table 1. Effect of pregnancy on haemorrgheologic and fibrinolytic parameters. 
 










PCV l/l 0.33 ± 0.04 0.31 ± 0.03 0.32 ± 0.01 0.36 ± 0.03 < 0.01 
RWBV 3.99 ± 0.4 4.01 ± 0.63 4.07 ± 0.69 4.23 ± 0.45 > 0.05 
RPV 1.65 ± 0.15 1.67 ± 0.16 1.72 ± 0.18 1.58 ± 0.17 < 0.01 
PFC (g/l) 3.3 ± 0.7 3.0 ± 0.8 3.3 ± 0.9 2.3 ± 1.2 < 0.01 
ELT (mins) 426.4 ± 66.0 371.7 ± 65.4 340.3 ± 76.4 270.5 ± 170.6 < 0.01 
Total protein (g/l) 62.8 ± 10.8 60.2 ± 9.8 61.5 ± 10.4 62.0 ± 10.1 > 0.05 
Albumin (g/l) 40.7 ± 10.2 36.3 ± 8.4 38.6 ± 7.4 38.3 ± 8.0 > 0.05 




able plastic syringe from each subject and 4.5 ml of it was mixed 
with 0.5 ml of 31.3 g/l sodium citrate solution while 2.5 ml of blood 
was added to di-potassium ethylene diamine tetra -acetic acid 
(EDTA) bottle to the final concentration of 1.5 mg/ml for the 
determination of packed cell volume (PCV) using standard micro-
haematocrit method (Bain and Bates, 2002). Whole blood viscosity 
(WBV) and plasma viscosity (PV) were determined using method of 
Reid and Ugwu (1987). Sample collected from each subject was 
analysed within 2 h for the purpose of precision and accuracy. In 
the calculations for relative plasma viscosity (RPV) and relative 
whole blood viscosity (RWBV), the mean values of the flow rates of 
whole blood (Tb), plasma (Tp) and distilled water (Tw) in s were 
applied as thus: 
 
RPV = Tp (s) /Tw (s) 
 
RWBV = Tb (s) / Tw (s) 
 
Blood sample in the citrated container was centrifuged at 2,500 g 
for 10 min to separate the plasma for the determination of plasma 
fibrinogen concentration by dry clot weight method of Ingram (1961) 
and euglobulin lysis time by Haugie method (Haugie, 1986) . 
The remaining 1 ml of blood was put in a plain bottle for the 
determination of total protein and albumin. Total protein determina-
tion using Biuret method was carried out by adding 1 ml of colour 
reagent to 20 µl of serum sample or standard in a test tube and the 
contents were mixed and incubated for 5 min at room temperature. 
The absorbance of the sample and the standard were measured 
against the reagent blank within 30 min while albumin concentration 
was determined using Randox Kit by adding 3.0 ml of BCG reagent 
(R1) to 0.01 ml of distilled water, standard and serum sample 
respectively in three different test – tubes. The contents were mixed 
and incubated for 5 min at room temperature and colorimetric 
measurement of the absorbance of the sample and standard 





Data generated were expressed as mean ± standard deviation 
while one-way analysis of variance (ANOVA) was used to compare 





Table 1 shows the effect of pregnancy on 
haemorrheologic and fibrinolytic parameters. The first, 
second  and  third  trimesters  had  lower  PCV  of  0.33 ±  
0.041, 0.31 ± 0.03 and 0.32 ± 0.01 l/l respectively as 
compared to 0.36 ± 0.03 l/l for non – pregnancy women 
and these differences were statistically significant (P < 
0.001). The values of RWBV in the first, second and third 
trimesters and non–pregnant women were 3.99 ± 0.4, 
4.01 ± 0.63, 4.07 ± 0.69 and 4.23 ± 0.45 respectively and 
these differences in values were not statistically signi-
ficant (P > 0.05). RPV values increased with gestational 
age as follows:  1.65 ± 0.15, 1.67 ± 0.16 and 1.72 ± 0.18 
for first, second and third trimesters, respectively, but 
when compared to 1.58 + 0.17 of non-pregnant women 
showed statistically significant increase (P < 0.01). The 
values of PFC in the first, second and third trimesters 
were 3.3 ± 0.7, 3.0 ± 0.8 and 3.3 ± 0.9 g/l respectively as 
compared to 2.3 ± 1.2 g/l for non-pregnant women (P < 
0.01). 
ELT values decreased with increase in gestational age 
as follows:- first, second and third trimesters values were 
426.4 ± 66.0 , 371.7 ± 65.4 and 340.3 ± 76.4 min 
respectively as compared to 270.5 ± 170.6 for non-preg-
nant subjects (P < 0.01). This implies that fibrinolytic 
activity increased as the pregnancy advanced. 
The differences in the values of total protein, albumin 
and globulin with regard to first, second and third trimes-
ters as compared to non-pregnant subjects were not 
statistically significant (P > 0.05). 
Table 2 shows changes in haemorrheologic and fibrino-
lytic parameters with gestational age. The differences in 
the values of PCV, RWBV, RPV, PFC, total proteins, 
albumin and globulin were not statistically significant (P > 
0.05) while the values of ELT decreased with gestational 
age (P < 0.01) which implies that fibrinolytic activity 
increased as the pregnancy advanced in age. 
Table 3 shows parity and changes in haemorrheologic 
and fibrinolytic parameters in pregnant women. The 
differences in the values of PCV (0.32 ± 0.041, 0.32 ± 
0.031 and 0.31 ± 0.04 l/l), RWBV (4.03 ± 0.43, 4.05 ± 
0.61 and 4.15 ± 1.13), RPV (1.73 ± 0.19, 1.69 ± 0.17 and 
1.7 ± 0.55), PFC (3.3 ± 0.8, 0.3.1 ± 0.8 and 3.4 ± 1.1 g/l), 
ELT (365.7 ± 94.0, 351.2 ± 83.2 and 334.5 ± 56.7 min), 
total protein (62.0 ± 9.9 , 61.4 ± 11.0 and 60.4 ± 12.6 g/l), 
albumin (38.1 ± 7.6, 37.8 ±  7.2  and  40.4  ±  9.0 g/l)  and 




Table 2. Effect of gestational age on haemorrheologic and fibrinolytic parameters. 
 
Parameter  1st Trimester 
(n = 10) 
2nd Trimester 
(n = 30) 
3rd Trimester 
(n = 60) 
P – Value 
PCV l/l 0.33 + 0.04 0.31 + 0.03 0.32 + 0.01 >0.05 
RWBV 3.99 + 0.4 4.01 + 0.63 4.07 + 0.69 > 0.05 
RPV 1.65 + 0.15 1.67 + 0.16 1.72 + 0.18 >0.05 
PFC g/l 3.3 + 0.7 3.0 + 0.8 3.3 + 0.9 >0.05 
ELT (mins) 426.4 + 66.0 371.7 + 65.4 340.3 + 76.4 <0.01 
Total proteins (g/l) 62.8 + 10.8 60.2 + 9.8 61.5 + 10.4 >0.05 
Albumin (g/l) 40.7 + 10.2 36.3 + 8.4 38.6 + 7.4 >0.05 




Table 3.  Parity and changes in haemorrheologic and fibrinolytic parameters in pregnant women. 
 







PCV l/l 0.32 ± 0.04 0.32 ± 0.03 0.31 ± 0.04 >0.05 
RWBV 4.03 ± 0.43 4.05 ± 0.61 4.15 ± 1.13 >0.05 
RPV 1.73 ± 0.19 1.69 ± 0.17 1.7 ± 0.55 >0.05 
PFC (g/l) 3.3 ± 0.8 3.1 ± 0.8 3.4 ± 1.1 >0.05 
ELT (mins) 365.7 ± 94.0 351.2 ± 83.2 334.5 ± 56.7 >0.05 
Total proteins (g/l) 62.0 ± 9.9 61.4 ± 11.0 60.4 ± 12.6 >0.05 
Albumin (g/l) 38.1 ± 7.6 37.8 ± 7.2 40.4 ± 9.0 >0.05 




globulin (20.6 ± 9.1, 20.5 ± 9.5 and 16.6 ± 8.5 g/l) for 0, 1, 
-2 and 3+ parities respectively were not statistically 
significant (P > 0.05). This implies that parity had no 





This study has shown that gestational age had no effect 
on PCV, RWBV, RPV, PFC, total proteins, albumin and 
globulin except ELT value which decreased as the 
pregnancy progressed and this implies that the fibrinolytic 
activity increased as the pregnancy advanced. The ELT 
result agrees with the report of Wright et al. (1988) but 
disagrees with the observation of Akinsete and Uyanwah 
(1989). The decreased ELT value as the pregnancy 
advanced in age reflects a gradual decline to normal 
fibrinolytic activity after delivery. Significant differences 
were observed in the values of PCV, RPV, PFC and ELT 
with regard to the first, second and third trimesters when 
compared to non-pregnant subjects (controls). These 
findings are in agreement with earlier authors (Adediran 
et al., 1999; Kametas et al., 2001; Usanga et al., 1994; 
Salawu and Durosinmi, 2001). However, the differences 
have been attributed to haemodilution, changes in the 
concentration of one or more plasma proteins fractions 
and reduced fibrinolytic activity in pregnancy (Koos and 
Moore, 2003; Stuart and Christoph, 2000) while total 
proteins, albumin and globulin concentrations have not 
shown significant differences in pregnancy in this study.  
Increase in the blood and plasma volumes during pregnancy 
varies due to the number of previous pregnancies, infants and 
fetuses (Koos and Moore, 2003). However, increased fibrinogen 
concentration during pregnancy is due to increase in its 
synthesis which has been associated with its utilization in the 
uteroplacentral circulation while prolonged ELT value 
reflects reduced fibrinolytic activity in this condition. 
These findings are in line with previous reports(Koos and 
Moore, 2003; Choi and Pai, 2002). 
It is concluded that gestational age had effect on the 
fibrinolytic activity since the decreased activity was gradually 
back to normal as the pregnancy advanced while parity had no 
effect on haemorrheologic and fibrinolytic activities in 
pregnancy. This study has shown that pregnancy may be 
associated with reduction in PCV and increase in RPV, PFC 
and ELT while gestation had no effect on PCV, RPV and 





Koos JB Moore JP (2003). Maternal Physiology during pregnancy. In 
H.D. Alan and N. Lauren, (Eds). Current obstetric and gynaecologic 
diagnosis and treatment, 9th edition. New York: Mc Graw Hill 
companies pp. 154-162. 
Stuart C, Christoph L (2000).  Physiological  changes  in  pregnancy.  In 




In obstetrics by ten teachers, 17th edition. Indian; Ajanta offset and 
Packagings Limited pp. 47-50. 
Tommaso MD, Ferretti C, Conforti D, D’Ancona RL, Baronci D, 
Cianciulli D, Branconi F (1991). Haematocrit and haemoglobin, 
parameters of hematic viscosity in pregnancy–induced hypertension. 
Minerva Ginecologica, 43 (5): 237-240 
Bennett B, Moore NR, Cruickshank DJ, Reith A, Booth WA (1993). 
Plasminogen activator inhibitors (PAI-1) and (PAI-2) in normal 
pregnancies, preeclampsia and hydatiform mole. British J. Obstetrics 
and Gynaecology, 100: 370-374. 
Adediran IA, Durosinmi MA, Ogunniyi SO, Akinola NO, Akanmu, AS 
(1999). Haemostatic parameters in normal pregnant Nigerians and 
Nigerians with hypertensive disorders of pregnancy. The Nigerian 
Postgraduate Med. J. 6(2): 49-52. 
Akinsete I, Uyanwah PO (1989). The fibrinolytic enzyme system in 
pregnancy in Nigerians. Afr. J. Med. Med. Sci. 18(2): 89-93. 
Kametas N, Krampl E, Mcauliffe F, Rampling MW, Nicolaides KH 
(2001). Haemorrheological adaptation during Pregnancy in a Latin 
American Population, Eur. J. Haematol. 66(5): 305-311. 
Harkness J, Whittington RB (1971). The viscosity of human blood 
plasma and its change in disease and on the exhibition of drugs. 
Rheologica Acta 10 (1): 1435-1528. 
Bain BJ, Bates I (2002). Basic haematological techniques. In S.M 
Lewis, B.J. Bain and I. Bates (Eds), Dacie and Lewis Practical 
haematology, 9th edition. London : Churchill Livingstone pp. 19-46. 
Reid HL, Ugwu AC (1987). A simple technique of rapid determination of 


















































Ingram GIC (1961). A suggested schedule for the rapid investigation of 
acute haemostatic failure. J. Clinical Pathol. 14, 156-160. 
Haugie C (1986). Euglobulin lysis time (method). In William JW, Benller 
E, Ersley AJ, Lichman N (Eds.), Haematology, 3rd edition. Singapore; 
M.C Graw Hill Books pp. 1670-1678. 
Wright JG, Cooper P, Astedt B, Lecander I Wilde JT, Preston FE, 
Greaves M (1988). Fibrinolysis during normal human pregnancy: 
complex inter-relationships between plasma levels of tissue 
plasminogen activator and inhibitors and the euglobulin clot lysis 
time. British J. Haematol. 69(2): 253-258 
Usanga, E.A., Chilaka, M. and Archibong, E.I. (1994). Prevalence of 
iron deficiency anaemia in Nigerian pregnant women. J. Med. 
Laboratory Sci. 4,107-113. 
Salawu, L. and Durosinmi, M.A. (2001). Erythrocyte rate and plasma 
viscosity in health and diseases. Nigeria Journal of Medicine, 10 (1): 
11 – 13. 
Choi JW, Pai SH (2002). Tissue plasminogen activator levels change 
with plasma fibrinogen concentrations during pregnancy. Annals of 
Haematol. 81 (11): 611 -615. 
 
 
 
 
